Compare GSIT & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSIT | NAGE |
|---|---|---|
| Founded | 1995 | 1999 |
| Country | United States | United States |
| Employees | N/A | 117 |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.9M | 169.1M |
| IPO Year | 2004 | 2010 |
| Metric | GSIT | NAGE |
|---|---|---|
| Price | $3.07 | $2.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.67 |
| AVG Volume (30 Days) | 467.8K | ★ 506.9K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.07 |
| Revenue | $25,122,000.00 | ★ $129,423,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.95 | $15.79 |
| P/E Ratio | ★ N/A | $29.50 |
| Revenue Growth | 22.44 | ★ 29.95 |
| 52 Week Low | $2.93 | $2.04 |
| 52 Week High | $13.00 | $7.12 |
| Indicator | GSIT | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 30.56 | 35.09 |
| Support Level | N/A | $2.04 |
| Resistance Level | $5.82 | $3.61 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 9.69 | 5.41 |
GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia and customers segregated as-Contract manufacturers, Distribution and OEMs. In addition, it serves the ongoing needs of the military, aerospace and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and USA.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.